OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synergistic antibacterial activity of tetrandrine combined with colistin against MCR-mediated colistin-resistant Salmonella
Kaifang Yi, Shuobo Liu, Peiyi Liu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112873-112873
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Synergistic Antibacterial Activity of Green Synthesized Silver Nanomaterials with Colistin Antibiotic against Multidrug-Resistant Bacterial Pathogens
Mohamed Taha Yassin, Ashraf Abdel‐Fattah Mostafa, Abdulaziz A. Al–Askar, et al.
Crystals (2022) Vol. 12, Iss. 8, pp. 1057-1057
Open Access | Times Cited: 39

The Combination of Antibiotic and Non-Antibiotic Compounds Improves Antibiotic Efficacy against Multidrug-Resistant Bacteria
Gang Xiao, Jiyun Li, Zhiliang Sun
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15493-15493
Open Access | Times Cited: 25

Synergistic Activity of Tetrandrine and Colistin against mcr-1-Harboring Escherichia coli
Muhammad Shafiq, Fen Yao, Hazrat Bilal, et al.
Antibiotics (2022) Vol. 11, Iss. 10, pp. 1346-1346
Open Access | Times Cited: 22

Efflux in Gram-negative bacteria: what are the latest opportunities for drug discovery?
Teresa Gil‐Gil, Pablo Laborda, Luz Edith Ochoa-Sánchez, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 6, pp. 671-686
Closed Access | Times Cited: 12

Synergistic Activity and Mechanism of Sanguinarine with Polymyxin B against Gram-Negative Bacterial Infections
Luyao Qiao, Yu Zhang, Ying Chen, et al.
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 70-70
Open Access | Times Cited: 4

Drug Repurposing Approaches towards Defeating Multidrug-Resistant Gram-Negative Pathogens: Novel Polymyxin/Non-Antibiotic Combinations
Augustine Jing Jie Koh, Maytham Hussein, Gauri G. Rao, et al.
Pathogens (2022) Vol. 11, Iss. 12, pp. 1420-1420
Open Access | Times Cited: 18

NhaA: A promising adjuvant target for colistin against resistant Escherichia coli
Xuelin Wang, Yong Cui, Zhaohui Wang, et al.
International Journal of Biological Macromolecules (2024) Vol. 268, pp. 131833-131833
Closed Access | Times Cited: 3

Detection of Antibiotic Resistance in Feline-Origin ESBL Escherichia coli from Different Areas of China and the Resistance Elimination of Garlic Oil to Cefquinome on ESBL E. coli
Yin-Chao Tong, Pengcheng Li, Yang Yang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9627-9627
Open Access | Times Cited: 7

Synergistic Antimicrobial Effect of Colistin in Combination with Econazole against Multidrug-Resistant Acinetobacter baumannii and Its Persisters
Miaomiao Xie, Kaichao Chen, Edward Wai‐Chi Chan, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 9

Salmonella Typhimurium with Eight Tandem Copies of blaNDM-1 on a HI2 Plasmid
Huijuan Song, Siyu Zou, Yi Huang, et al.
Microorganisms (2023) Vol. 12, Iss. 1, pp. 20-20
Open Access | Times Cited: 4

Mechanism of antibacterial phytoconstituents: an updated review
Sageer Abass, Rabea Parveen, Mohammad Irfan, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 7
Closed Access | Times Cited: 1

Mechanism of synergistic action of colistin with resveratrol and baicalin against mcr-1-positive Escherichia coli
Ping Cheng, Yingying Sun, Botao Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117487-117487
Open Access | Times Cited: 1

Colistin–niclosamide-loaded nanoemulsions and nanoemulsion gels for effective therapy of colistin-resistant Salmonella infections
Junkai Zhang, Xilong Wang, Pengliang Li, et al.
Frontiers in Veterinary Science (2024) Vol. 11
Open Access | Times Cited: 1

Tetrandrine Derivatives as Promising Antibacterial Agents
Viviana Calvillo‐Páez, Maribel Plascencia‐Jatomea, Adrián Ochoa‐Terán, et al.
ACS Omega (2023) Vol. 8, Iss. 31, pp. 28156-28164
Open Access | Times Cited: 3

A novel class of C14-sulfonate-tetrandrine derivatives as potential chemotherapeutic agents for hepatocellular carcinoma
Tai‐Bai Jiang, Guangtong Xie, Zhirui Zeng, et al.
Frontiers in Chemistry (2023) Vol. 10
Open Access | Times Cited: 2

Making a chink in their armor: Current and next-generation antimicrobial strategies against the bacterial cell envelope
Nikol Kadeřábková, Ayesha J. S. Mahmood, R. Christopher D. Furniss, et al.
Advances in microbial physiology/Advances in Microbial Physiology (2023), pp. 221-307
Closed Access | Times Cited: 2

The antihelminth drug rafoxanide reverses chromosomal-mediated colistin-resistance in Klebsiella pneumoniae
Rong-jia Han, Jiabao Xing, Huarun Sun, et al.
mSphere (2023) Vol. 8, Iss. 5
Open Access | Times Cited: 2

Preparation of Tetrandrine Nanocrystals by Microfluidic Method and Its In Vitro and In Vivo Evaluation
Jinping Huang, Shuwen Huang, Shengjun Liu, et al.
AAPS PharmSciTech (2023) Vol. 25, Iss. 1
Closed Access | Times Cited: 2

Artesunate, EDTA and colistin work synergistically against MCR-negative and -positive colistin-resistantSalmonella
Yajun Zhai, Peiyi Liu, Xueqin Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Page 1 - Next Page

Scroll to top